Effects of SGLT2 inhibitors on haematocrit and haemoglobin levels and the associated cardiorenal benefits in T2DM patients: A meta‐analysis

To explore the effect and magnitude of effect of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors on haematocrit and haemoglobin and the related cardiorenal benefits in patients with type 2 diabetes mellitus (T2DM), PubMed, Web of Science, CENTRAL and EMBASE were searched to identify eligible trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Qi, Guo, Keyu, Deng, Jiayi, Zhong, Yanjun, Yang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814934/
https://www.ncbi.nlm.nih.gov/pubmed/34878225
http://dx.doi.org/10.1111/jcmm.17115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814934/
https://www.ncbi.nlm.nih.gov/pubmed/34878225
http://dx.doi.org/10.1111/jcmm.17115

Ejemplares similares